Clin2
NCT06885996Possibly a fitNot yet recruiting

Psilocybin therapy for PTSD from partner violence

Post Traumatic Stress Disorder PTSDIntimate Partner Violence (IPV)

Treatments studied

Part of Mental health clinical trials.

This trial tests whether psilocybin, a substance that can help the brain process trauma, combined with therapy can reduce PTSD symptoms in people who have experienced intimate partner violence. You must be at least 6 months past the last incident and not have serious health or mental health issues.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
76 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 19 and 65 years old.
  • You have experienced partner violence at least 6 months ago, and it happened more than once.
  • You have PTSD symptoms (score of 33 or higher on a standard PTSD test).
  • You have little or no past use of hallucinogens like psilocybin or LSD.
  • You are not currently pregnant, nursing, or trying to get pregnant.
  • You do not have certain medical conditions like epilepsy, insulin-dependent diabetes, or a recent head injury.
  • You are not actively suicidal or have attempted suicide in the past year.
  • You do not have a history of schizophrenia or bipolar disorder in yourself or a close family member.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07737054Recruiting· Early Phase 1
Psilocybin therapy for PTSD

This trial tests a type of therapy that uses psilocybin (a safe, natural substance found in certain mushrooms) to help people with PTSD. It combines talk therapy with the medicine to see if it can reduce trauma symptoms.

Tel Aviv
NCT07703722Recruiting· Phase 3
Psilocybin and therapy for depression with trauma

This trial tests psilocybin (a compound from certain mushrooms) combined with a structured therapy to see if it helps people with depression linked to trauma. It focuses on how the treatment affects the connection between the gut and brain.

Islamabad, Capital
NCT05995769Recruiting· Phase 2
Psilocybin therapy with talk therapy for alcohol problems

This trial tests whether psilocybin (the active ingredient in magic mushrooms), given with talk therapy, can help people who want to reduce their heavy drinking. It is for people with at least moderate alcohol use disorder who are motivated to change.

Calgary, Alberta
NCT06902974Recruiting· Phase 2
Psilocybin therapy for PTSD from sexual assault

This trial tests whether psilocybin, a psychedelic drug given in a supportive therapy setting, can help women heal from post-traumatic stress disorder (PTSD) caused by a sexual assault that happened 6 or more months ago. You'll receive the drug during supervised sessions and attend therapy visits to see if it reduces your PTSD symptoms.

Rockville, Maryland
NCT06386003Recruiting· Phase 2
Psilocybin and talk therapy for chronic PTSD

This trial tests whether a medication called psilocybin (the active ingredient in magic mushrooms) can help people with long-term PTSD when combined with a specific type of talk therapy. The goal is to see if this approach reduces PTSD symptoms more than therapy alone.

Toronto, Ontario
NCT07506395Recruiting· Phase 1
Psilocybin group therapy for PTSD

This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.

Albuquerque, New Mexico

Hear when a new Intimate Partner Violence (IPV) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.